Table 3. Categorization of studies on therapeutic approach.
|
|
Relevance for inclusion | Results and conclusions |
---|---|---|---|
|
|
New potential treatments for pertussis | Clinical studies needed to evaluate effectiveness of Pendrin and Acetazolamide |
|
|
Review of microbiology, clinical aspects, treatment and prevention | Comprehensive review on pertussis |
|
|
Duration of treatment with clarithromycin | Positive PCR tests after seven days of clarithromycin |
|
|
Review of epidemiology, diagnosis, treatment and prevention | Broad review |
|
|
Severe pertussis: supportive treatment | Hyperleukocytosis reduced by Nitric oxide Exchange transfusion indicated for pulmonary hypertension |
|
|
Time of erythromycin use for bacteria eradication | Seven days of erythromycin as effective as 14 days for bacterial eradication in the nasopharynx |
|
|
Treatment and prophylaxis of pertussis | All macrolides eradicate bacteria but do not alter the course of the disease |
|
|
Classical study: use of erythromycin for treatment and prevention | Erythromycin more effective than other antibiotics for bacterial eradication |
|
Recommendation | Antibiotic therapy and chemoprophylaxis | Recommends replacement of erythromycin with azithromycin |
|
|
Azithromycin and erythromycin Eradication of bacteria, clinical and adverse effects | Seven days of azithromycin as effective as 14 days of erythromycin, with fewer adverse effects |
|
|
Resistance of B. pertussis to erythromycin | Resistance of B. pertussis to erythromycin was uncommon (1985 to 1997) |
|
|
Clarithromycin and azithromycin: efficacy and safety | Clarithromycin as effective as erythromycin with fewer side effects |
|
|
Hypertrophic pyloric stenosis as an adverse effect of macrolides | Use of macrolides in neonates increased the risk of hypertrophic pyloric stenosis |
|
|
Severe pertussis: clinic and severity criteria | Apnea and early paroxysms (less than a week of symptoms) are signs of severity and require ICU admission |
|
|
Severe pertussis: supportive treatment | Exchange transfusion effective for leukoreduction |
|
Descriptive study10 | Severe pertussis: supportive treatment | Exchange transfusion effective if performed early, before organ failure |
|
Descriptive study19 | Severe pertussis: supportive treatment | Leukoreduction therapies may be considered safe in critically ill patients |
|
|
Severe pertussis: supportive treatment | There was success in treatment with leukopheresis |
|
|
Severe pertussis: supportive treatment | Use of ECMO was controversial. All patients died. |
|
|
Symptomatic treatment of pertussis | No symptomatic treatment of cough was effective |
PCR: polymerase chain reaction; ICU: Intensive Care Unit; ECMO: Extracorporeal Membrane Oxygenation.